戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 g the formation of non-secreting, aggressive pituitary tumours.
2 ubtypes of ACTH-secreting and possibly other pituitary tumours.
3 ent in human corticotrophin (ACTH)-secreting pituitary tumours.
4 sult in young-onset growth hormone secreting pituitary tumours.
5 (P-NETs) in association with parathyroid and pituitary tumours.
6  and increased predisposition to ovarian and pituitary tumours(2-4).
7 ing the likelihood of complete resection for pituitary tumours and gliomas.
8                 Of a further three malignant pituitary tumours assessed, two (including a prolactinom
9 f the GADD45gamma gene was also found in the pituitary tumour cell line AtT20.
10        Consultation with a multidisciplinary pituitary tumour centre of excellence should be consider
11  to adulthood should ideally be managed at a pituitary tumour centre of excellence.
12 orticotropic hormone (ACTH) secretion from a pituitary tumour (Cushing disease (CD)) or non-pituitary
13 tuitary tumour (Cushing disease (CD)) or non-pituitary tumour (ectopic ACTH secretion), which stimula
14   In this study we have examined 32 sporadic pituitary tumours for expression of the DAP kinase prote
15 lary craniopharyngioma (PCP), a benign human pituitary tumour harbouring BRAF p.V600E also contains S
16 r protein products are a frequent finding in pituitary tumours; however, genetic changes associated w
17                           The only malignant pituitary tumour in the original series showed an absenc
18 ow that silencing of the GADD45gamma gene in pituitary tumours is primarily associated with methylati
19                                We studied 21 pituitary tumours, of which 20 were ACTH-secreting (two
20 phenotype associated with the development of pituitary tumours, specifically those of the intermediat
21                                              Pituitary tumour transforming gene (PTTG) is a proto-onc
22                                          The pituitary tumour transforming gene (PTTG), also known as
23 yclin A and CDC2 and novel targets including pituitary tumour transforming gene 1, Polo-like kinase 1
24                                              Pituitary-tumour transforming gene (PTTG1) causes in-vit
25    In adult cohorts separately, rs1344110 in pituitary tumour-transforming 1 interacting protein (PTT
26 TTG1IP showed significant co-expression with pituitary tumour-transforming 1, the binding factor of P
27 re an approximate 10-fold down-regulation of pituitary tumour-transforming gene-1 (pttg1) and an appr
28 clinical characteristics of 84 patients with pituitary tumour who had troublesome headache were inves